HomepageCRL • NYSE
add
Charles River Laboratories
$Â 155,46
Na sluitingstijd:(0,00%)0,00
$Â 155,46
Gesloten: 13 mrt, 16:03:45 GMT-4 · USD · NYSE · Disclaimer
Vorige slotkoers
$Â 152,66
Dag-range
$Â 153,04 - $Â 158,76
Jaar-range
$Â 91,86 - $Â 228,88
Beurswaarde
7,65Â mld. USD
Gem. volume
1,19Â mln.
Koers/winst
-
Dividendrendement
-
Primaire beurs
NYSE
In het nieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
| (USD) | dec 2025info | Wijziging j-o-j |
|---|---|---|
Opbrengst | 994,23Â mln. | -0,83% |
Bedrijfskosten | 284,04Â mln. | 21,15% |
Netto inkomsten | -276,56Â mln. | -28,93% |
Netto winstmarge | -27,82 | -30,06% |
Winst per aandeel | 2,39 | -10,15% |
EBITDA | 169,61Â mln. | 12,90% |
Effectief belastingtarief | 6,06% | — |
Balans
Totale activa
Totale passiva
| (USD) | dec 2025info | Wijziging j-o-j |
|---|---|---|
Contanten en kortetermijnbeleggingen | 213,77Â mln. | 9,85% |
Totale activa | 7,14Â mld. | -5,22% |
Totale passiva | 3,92Â mld. | -2,39% |
Totaal aandelenvermogen | 3,21 mld. | — |
Uitstaande aandelen | 49,23 mln. | — |
Koers-boekwaardeverhouding | 2,37 | — |
Rendement op activa | 1,53% | — |
Rendement op kapitaal | 1,88% | — |
Kasstroom
Nettomutatie in liquide middelen
| (USD) | dec 2025info | Wijziging j-o-j |
|---|---|---|
Netto inkomsten | -276,56Â mln. | -28,93% |
Operationele kasstroom | 147,52Â mln. | -7,43% |
Kasstroom uit beleggingen | -92,81Â mln. | -21,95% |
Kasstroom uit financiering | -51,86Â mln. | 31,65% |
Nettomutatie in liquide middelen | 6,78Â mln. | 211,65% |
Vrije kasstroom | 98,35Â mln. | 112,34% |
Over
Charles River Laboratories International, Inc. is an American pharmaceutical and biotechnology contract research organisation headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices. Its operations span at least 20 countries, offering research models, safety assessment, and manufacturing support services to pharmaceutical, biotechnology, and government clients.
Charles River Laboratories is considered one of the largest CROs globally, known for its role in toxicology studies, animal research models, and microbial testing services used in regulatory submissions to health authorities such as the U.S. Food and Drug Administration. The company has also been the subject of public scrutiny and regulatory attention over its use of laboratory animals, including dogs, primates, and horseshoe crabs.
As of 2024, the company employs over 20,000 people worldwide and is publicly traded on the New York Stock Exchange under the ticker symbol CRL. Wikipedia
Opgericht
1947
Hoofdvestiging
Website
Werknemers
19.000